Search

Setting the stage for individualized cancer treatment with a simple blood test

SETTING THE STAGE FOR INDIVIDUALIZED CANCER TREATMENT WITH A SIMPLE BLOOD TEST

One emerging approach in the diagnosis of cancer is known as a “liquid biopsy.” Instead of using a tiny snippet of tissue to characterize...

FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take

FDA OKS DEPRESSION DRUG FOR NEW MOMS: FAST RELIEF BUT TOUGH TO TAKE

The FDA has just made brexanolone the first medicine approved specifically for post-partum depression, a potentially devastating disorder...

 
 
 

FATE THERAPEUTICS, INC.: REGULATORY AFFAIRS / OPERATIONS MANAGER

Fate Therapeutics, Inc.: Fate Therapeutics, Inc. is seeking an experienced and highly motivated regulatory professional to support...

ZEBRAFISH AS A MODEL FOR KIDNEY FUNCTION AND DISEASE

Abstract Kidney disease is a global problem with around three million people diagnosed in the UK alone and the incidence is rising....

 
 
 

SCIENTIST PROTEIN CHEMISTRY - JOHNSON & JOHNSON FAMILY OF COMPANIES - SAN DIEGO, CA

Or equivalent degree with 0-3 years of experience, preferably in a biotech research environment. The Janssen Bio Therapeutics organization...

PHAGE DISPLAY DERIVED THERAPEUTIC ANTIBODIES HAVE ENRICHED ALIPHATIC CONTENT: INSIGHTS FOR DEVELOPABILITY ISSUES

Abstract Phage display is one of the most widely used technology for antibody discovery and engineering. Number of therapeutic antibodies...

 
 
 
How To Explain Your Breakup To Your Friends, Because It Can Be Tough To Open Up

HOW TO EXPLAIN YOUR BREAKUP TO YOUR FRIENDS, BECAUSE IT CAN BE TOUGH TO OPEN UP

Dealing with the fallout of a breakup is brutal enough. And although talking it out with your friends may be therapeutic in many ways,...

ALLERGY THERAPEUTICS' SHARES NOSE-DIVE AS ANOTHER SETBACK HITS THE BIOTECH

Allergy Therapeutics saw its stock down by 40% in early trading in London Monday morning after its birch pollen drug failed to move...

 
 
 

CROSS‐LINKED ENZYME AGGREGATES OF RECOMBINANT CANDIDA ANTARCTICA LIPASE B FOR THE EFFICIENT SYNTHESIS OF OLVANIL, A NON‐PUNGENT CAPSAICIN ANALOGUE

Despite the proven therapeutic role of capsaicin in human health, its usage is still hampered by its high pungency. In this sense,...

FATE THERAPEUTICS, INC.: CLINICAL TRIAL ASSOCIATE

Fate Therapeutics, Inc.: Fate's clinical operations group is seeking a motivated and talented individual to support development and...

 
 
 

ALLERGY THERAPEUTICS' SHARES NOSEDIVE AS ANOTHER SETBACK HITS THE BIOTECH

Allergy Therapeutics saw its stock down by 40% in early trading in London Monday morning after its birch pollen drug failed to move...

Bio Roundup: Golumbeski's Legacy, CRISPR Moratorium, Rebate Week & More

BIO ROUNDUP: GOLUMBESKI'S LEGACY, CRISPR MORATORIUM, REBATE WEEK & MORE

While all eyes in the biopharmaceutical world are currently trained on Bristol-Myers Squibb's proposal to buy Celgene for $74 billion...

 
 
 
Gene Therapy Boom, Cracking Alzheimer's: What's Hot on May 21

GENE THERAPY BOOM, CRACKING ALZHEIMER'S: WHAT'S HOT ON MAY 21

Our annual half-day life sciences variety show, “ What's Hot in Biotech ,” is back. Join Xconomy on May 21 at Bristol-Myers Squibb's...

The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski

THE LIFE, TROUBLES, AND CELGENE LEGACY OF DEAL GURU GEORGE GOLUMBESKI

George Golumbeski is one of the most prolific dealmakers in the biopharmaceutical world. But the deal that changed his life is a pact...

 
 
 

77% OF PATIENTS REMAIN OPIOID-FREE WHEN HTX-011 IS GIVEN WITH AN OVER-THE-COUNTER ANALGESIC REGIMEN IN NEW MULTI-CENTER POSTOPERATIVE PAIN MANAGEMENT STUDY IN BUNIONECTOMY

Bunionectomy Results Complement Opioid-Free Results from the Previously Reported Hernia Repair Study - SAN DIEGO, March 11, 2019 /PRNewswire/...

The Life, Troubles, And Celgene Legacy of Deal Guru George Golumbeski

THE LIFE, TROUBLES, AND CELGENE LEGACY OF DEAL GURU GEORGE GOLUMBESKI

George Golumbeski is one of the most prolific dealmakers in the biopharmaceutical world. But the deal that changed his life is a pact...

 
 
 

NANOSCALE MONITORING OF MITOCHONDRIA AND LYSOSOME INTERACTIONS FOR DRUG SCREENING AND DISCOVERY

Abstract Technology advances in genomics, proteomics, and metabolomics largely expanded the pool of potential therapeutic targets....

THERAPEUTIC TARGETS AND MICROENVIRONMENT IN SEQUENTIAL BIOPSIES OF CLASSICAL HODGKIN LYMPHOMA AT DIAGNOSIS AND RELAPSE

Abstract Classical Hodgkin lymphoma is dominated by the non-neoplastic microenvironment, while the neoplastic Hodgkin-Reed-Sternberg...

 
 
 
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs

BEAM BRINGS IN $135M TO TURN CRISPR BASE EDITING INTO DRUGS

Beam Therapeutics made a splash last year when it launched with $87 million to develop medicines that use a more precise form of CRISPR...

HERON THERAPEUTICS TO PRESENT AT THE 39TH ANNUAL COWEN HEALTHCARE CONFERENCE

SAN DIEGO, March 4, 2019 /PRNewswire/ - Heron Therapeutics, Inc. , a commercial-stage biotechnology company focused on improving the...